Characterization of T/B cell antigen specific-engineered tumors for studying T cell and GC B cell function in a murine model of NSCLC

Authors

Armando J. Ruiz-Justiz, University of Puerto Rico - Medical Sciences Campus
Mona Yazdani, The University of Texas MD Anderson Cancer Center
Xin Sun, The University of Texas MD Anderson Cancer Center
Lili Chen, The University of Texas MD Anderson Cancer Center
Michael Wang, The University of Texas MD Anderson Cancer Center
John Le, The University of Texas MD Anderson Cancer Center
Haiping Guo, The University of Texas MD Anderson Cancer Center
Can Cui, Yale University School of Medicine
Kelli Cannolly, Yale University School of Medicine
Aya Tal, Yale University School of Medicine
Wei Hu MD, PhD, The University of Texas MD Anderson Cancer Center
Nikhil Joshi PhD, Yale University School of Medicine
Tina Cascone MD, PhD, The University of Texas MD Anderson Cancer Center

Files

Abstract

View full abstract

DOI

https://doi.org/10.52519/00080

Publication Date

11-2022

Department

Thoracic Head and Neck Medical Oncology

Research Category

Unleashing the Immune System to Develop Therapeutic Strategies

Recommended Citation

Ruiz-Justiz, Armando J.; Yazdani, Mona; Sun, Xin; Chen, Lili; Wang, Michael; Le, John; Guo, Haiping; Cui, Can; Cannolly, Kelli; Tal, Aya; Hu, Wei MD, PhD; Joshi, Nikhil PhD; and Cascone, Tina MD, PhD, "Characterization of T/B cell antigen specific-engineered tumors for studying T cell and GC B cell function in a murine model of NSCLC" (2022). Leading Edge of Cancer Research Symposium. 14.
doi:https://doi.org/10.52519/00080